Please assess the completion status of the following clinical trial:

Trial Title: Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 8.0

Eligibility Criteria:
Inclusion Criteria:~* Have best corrected visual acuity of 0.60 logMAR or better in each eye as measured using Early Treatment of Diabetic Retinopathy Study chart~Exclusion Criteria:~* Have a known allergy and/or sensitivity to the test article(s) or its components or any therapies associated with the trial~* Have active signs or symptoms of any clinically significant ocular disorder (other than refractive disorders)~* Have a known bleeding disorder or history of bleeding complications after surgical or dental procedures~* Take aspirin, or take any other blood thinners or anti-coagulants (e.g. warfarin) including prescription, over the counter, or homeopathic therapies~* Have undergone any ocular surgical intervention within 3 months prior to Visit 1 or anticipate having ocular surgery during the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Azithromycin-30 minutes Post dose (Type: EXPERIMENTAL): None
- Azithromycin-2 hours post dose (Type: EXPERIMENTAL): None
- Azithromycin-12 hours post dose (Type: EXPERIMENTAL): None
- Azithromycin-24 hours post dose (Type: EXPERIMENTAL): None
- Moxifloxacin-30 minutes post dose (Type: EXPERIMENTAL): None
- Moxifloxacin-2 hours post dose (Type: EXPERIMENTAL): None
- Moxifloxacin-12 hours post dose (Type: EXPERIMENTAL): None
- Moxafloxacin-24 hours post dose (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).